Compare Edwards Lifesciences Corporation Common Stock (EW) vs iShares Russell 2000 ETF (IWM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Edwards Lifesciences Corporation Common Stock vs iShares Russell 2000 ETF — how do they compare? Edwards Lifesciences Corporation Common Stock trades at $85.25 (market cap $48.56B), while iShares Russell 2000 ETF trades at $279 (market cap $77.70B). The key difference: iShares Russell 2000 ETF is the larger of the two by market cap, and iShares Russell 2000 ETF is more actively traded (35,598,983 versus 6,520,488). Which is the better fit depends on your goals.
| EW | IWM | |
|---|---|---|
Market Cap | $48.56B | $77.70B |
Volume | 6,520,488 | 35,598,983 |
Sector | Health | — |
52-Week High | $95.18 | $305.06 |
52-Week Low | $72.65 | $229.13 |
Enterprise Value | $45.01B | — |
Typical Hold Time | — | 83 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
IWM, the iShares Russell 2000 ETF tracking US small-cap stocks, trades at $279.1, up 0.5% on the day. Technical indicators are predominantly bearish, with moving averages and ADX signaling a downtrend, though oscillators like RSI are neutral. The fund lacks traditional valuation ratios as it is an ETF, and recent news highlights its underperformance versus the S&P 500 over the past decade, with concerns about its inclusion of unprofitable companies.
The outlook for IWM is clouded by persistent underperformance and sensitivity to interest rate hikes, which pressure small caps. While offering diversification away from large-cap tech, the fund faces headwinds from economic tightening and narrow market breadth. A rebound hinges on broader market participation and favorable macroeconomic conditions, but near-term risks remain elevated.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Edwards Lifesciences Corporation Common Stock
Edwards Lifesciences develops medical technologies for structural heart disease. Its products include transcatheter aortic-valve replacement, mitral and tricuspid therapies, and surgical structural-heart technologies.
Read more on EW →About iShares Russell 2000 ETF
The ETF is designed to track the performance of the securities and the stocks in the Russell 2000 Index. To maintain the composition and weightings, the advisor adjusts the ETF from time to time to conform to periodic changes in the index target.
Read more on IWM →
